California Attorney General Secures Corporate Practice of Medicine (CPOM) Settlement Requiring Carbon Health to Restructure Its “Friendly PC” Arrangement

On June 26, 2026, California Attorney General Rob Bonta announced a settlement with Carbon Health Technologies, Inc., its affiliated professional medical corporations, and co-founder and former CEO, Eren Bali (collectively, “Carbon Health”) that imposes $4.5 million in combined penalties and requires a structural reorganization of Carbon Health’s “friendly PC” arrangements to resolve alleged violations of […]

California Attorney General Secures Corporate Practice of Medicine (CPOM) Settlement Requiring Carbon Health to Restructure Its “Friendly PC” Arrangement Read More »

Cardiff Lexington Announces the Addition of Southeastern Surgery Center in Tallahassee, Florida to Nova Ortho and Spine Network

Cardiff Lexington Corporation (OTCQX:CDIX) (“Cardiff Lexington” or the “Company”), a healthcare services holding company focused on orthopedic, spine, and pain management platforms, announces that its Nova Ortho and Spine subsidiary has added Southeastern Surgery Center in Tallahassee, Florida to its growing network of surgical facilities, enhancing access to advanced orthopedic and spine care for patients

Cardiff Lexington Announces the Addition of Southeastern Surgery Center in Tallahassee, Florida to Nova Ortho and Spine Network Read More »

Carolina Eye Associates Acquires Southeastern Eye Care

Carolina Eye Associates, P.A. has announced the acquisition of Southeastern Eye Care, the long-standing ophthalmology practice of Dr. Scott Mouser in Lumberton. The practice will now operate as the newest Carolina Eye Associates Lumberton clinic, strengthening CEA’s commitment to providing comprehensive, patient-centered eye care throughout the region. Dr. Mouser and his professional staff will continue

Carolina Eye Associates Acquires Southeastern Eye Care Read More »

AMR Clinical Acquires ClinOhio Research Services

AMR Clinical (AMR), an award-winning multi-site research company, has acquired ClinOhio Research Services (ClinOhio), a multi-therapeutic research site founded in 2017 and based in Columbus, Ohio. The acquisition expands AMR’s geographic presence and strengthens capabilities in Dermatology, Women’s Health, and Gastroenterology. “ClinOhio brings experienced investigators, strong patient relationships, and a clear commitment to high-quality research.

AMR Clinical Acquires ClinOhio Research Services Read More »

Ipsen Pens $1.7B Deal to Acquire Kartos for Potential Jakafi Add-On Therapy for Myelofibrosis

Ipsen is paying $450 million upfront to buy U.S.-based Kartos Therapeutics for a phase 3-stage blood cancer drug designed to improve on Jakafi treatment. The acquisition of Kartos gives the French biopharma access to an oral MDM2 inhibitor called navtemadlin. The drug is aimed at restoring the function of p53, a critical tumor suppressor in

Ipsen Pens $1.7B Deal to Acquire Kartos for Potential Jakafi Add-On Therapy for Myelofibrosis Read More »

Theravance Biopharma Enters into Definitive Agreement to Be Acquired by Zymeworks for $17.00 per Share in Cash Plus a Contingent Value Right

Theravance Biopharma, Inc. (“Theravance Biopharma” or the “Company”) (Nasdaq: TBPH) announces that it has entered into a definitive agreement pursuant to which Zymeworks Inc. will acquire the Company for $17.00 per share in cash, representing an equity value of approximately $929 million. In addition to the cash consideration, Theravance Biopharma shareholders will receive a CVR

Theravance Biopharma Enters into Definitive Agreement to Be Acquired by Zymeworks for $17.00 per Share in Cash Plus a Contingent Value Right Read More »

Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement

Talawar Tx Inc. (“Talawar” or “Talawar Therapeutics”), a biotechnology company developing potentially best-in-class bispecific antibodies that pair independent immunology & inflammatory (I&I) disease drivers in a single therapy, targeting pathways that work together for greater, more durable impact, and JATT II Acquisition Corp (Nasdaq: JATT) (“JATT II”), a special purpose acquisition company focused on building

Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement Read More »

Ascension Via Christi Acquires Former Rock Regional Hospital

The former Rock Regional Hospital in Derby will soon be known as Ascension Via Christi St. Peter. The hospital system announced that it has acquired the hospital, which closed in January after filing for bankruptcy protection the previous month. Via Christi said the next step will be getting the 90,000-square-foot facility in operating condition and

Ascension Via Christi Acquires Former Rock Regional Hospital Read More »

Scaling Cardiology: How Site-of-Care Strategy Is Reshaping M&A

Cardiology transaction activity remains strong, but the underlying investment strategy has evolved significantly over the last several years. Historically, many cardiovascular procedures were confined to the hospital setting because Medicare reimbursement and regulatory limitations restricted migration to outpatient settings. Today, that dynamic is changing rapidly. Expanded reimbursement eligibility, advancements in procedural technology, and growing confidence

Scaling Cardiology: How Site-of-Care Strategy Is Reshaping M&A Read More »

Scroll to Top